Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 GBX | 0.00% | 0.00% | -37.39% |
May. 07 | Abingdon Health buys IVDeology Holdings | AN |
Apr. 18 | Cadence Minerals submits Amapa Project environmental reports early | AN |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 19.6 | 7.115 |
Enterprise Value (EV) 1 | 19.6 | 6.805 |
P/E ratio | -3.38 x | -3.27 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | -3.78 x |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | - | - |
Nbr of stocks (in thousands) | 172,720 | 197,638 |
Reference price 2 | 0.1135 | 0.0360 |
Announcement Date | 6/27/23 | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net sales 1 | - | - |
EBITDA 1 | - | -1.8 |
EBIT 1 | - | -1.8 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | - | -1.8 |
Net income 1 | -5.497 | -1.8 |
Net margin | - | - |
EPS 2 | -0.0336 | -0.0110 |
Free Cash Flow | - | - |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 6/27/23 | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | - | 0.31 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | - |
ROA (Net income/ Total Assets) | - | - |
Assets 1 | - | - |
Book Value Per Share | - | - |
Cash Flow per Share | - | - |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 6/27/23 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.39% | 8.9M | |
+5.84% | 10.24B | |
-4.19% | 4.23B | |
+26.08% | 2.85B | |
-18.74% | 2.67B | |
+4.03% | 2.57B | |
+60.21% | 433M | |
+15.15% | 290M | |
+22.69% | 207M | |
-20.08% | 120M |
- Stock Market
- Equities
- REM Stock
- Financials Cadence Minerals Plc